CORRESP Filing
Terns Pharmaceuticals, Inc.
Date: May 21, 2025 · CIK: 0001831363 · Accession: 0001193125-25-123936
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287092
Letter
Re: Terns Pharmaceuticals, Inc. Registration Statement on Form S-3 File No. 333-287092 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Terns Pharmaceuticals, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-287092), so that it may become effective at 4:00 p.m., Eastern time, on May 23, 2025, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
Terns Pharmaceuticals, Inc. 1065 East Hillsdale Blvd. Suite 100 Foster City, California 94404 May 21, 2025 VIA EDGAR SUBMISSION U.S. Securities and Exchange Commission Division of Corporation Finance, Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Daniel Crawford
Very truly yours,
TERNS PHARMACEUTICALS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Terns Pharmaceuticals, Inc. 1065 East Hillsdale Blvd. Suite 100 Foster City, California 94404 May 21, 2025 VIA EDGAR SUBMISSION U.S. Securities and Exchange Commission Division of Corporation Finance, Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Daniel Crawford Re: Terns Pharmaceuticals, Inc. Registration Statement on Form S-3 File No. 333-287092 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Terns Pharmaceuticals, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-287092), so that it may become effective at 4:00 p.m., Eastern time, on May 23, 2025, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. Very truly yours, TERNS PHARMACEUTICALS, INC. By: /s/ Andrew Gengos Name: Andrew Gengos Title: Chief Financial Officer